Media Apperances

2021

  • Sep 24
    Animal Pharm

    Fatro secures European authorization for rabbit vaccine with Algenex tech

    The European Comission has granted marketing approval to a rabiit hemorrhagic disease virus (RHVD) from Italian business Fatro. The vaccine incorporates CrisBio technology developed by Spain´s Algenex.

    Read more

2020

  • Jan 24
    Labiotech.eu

    Algenex featured as Biotech of the Week by LaBiotech

    Madrid-based company Algenex is using moths as natural bioreactors to improve the speed and scalability of making proteins used in vaccines and diagnostics.

    Read more

2018

  • Jun 07
    Pharma Boardroom

    Interview to Dr. José Escribano, founder of Algenex

    The initial idea for ALGENEX was developed at a conference in Canada in the 1990s. Conversing with an American colleague in a Poxvirus meeting, we realised the huge potential for the use of living organisms in the production of recombinant proteins, and from that conversation, we began collaborating.

    Read more
Logo Algenex cookies
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.